These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1373513)

  • 1. Endotoxin-neutralizing capacity of soluble CD14.
    Schütt C; Schilling T; Grunwald U; Schönfeld W; Krüger C
    Res Immunol; 1992 Jan; 143(1):71-8. PubMed ID: 1373513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
    Schütt C; Schilling T; Krüger C
    Allerg Immunol (Leipz); 1991; 37(3-4):159-64. PubMed ID: 1724353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U; Krüger C; Schütt C
    Circ Shock; 1993 Mar; 39(3):220-5. PubMed ID: 7680967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.
    Loppnow H; Stelter F; Schönbeck U; Schlüter C; Ernst M; Schütt C; Flad HD
    Infect Immun; 1995 Mar; 63(3):1020-6. PubMed ID: 7532623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages.
    Landmann R; Fisscher AE; Obrecht JP
    J Leukoc Biol; 1992 Sep; 52(3):323-30. PubMed ID: 1381744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis.
    Labeta MO; Durieux JJ; Spagnoli G; Fernandez N; Wijdenes J; Herrmann R
    Immunology; 1993 Nov; 80(3):415-23. PubMed ID: 7507090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
    Stelter F; Witt S; Fürll B; Jack RS; Hartung T; Schütt C
    Eur J Clin Invest; 1998 Mar; 28(3):205-13. PubMed ID: 9568466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte CD14 is upregulated by lipopolysaccharide.
    Landmann R; Knopf HP; Link S; Sansano S; Schumann R; Zimmerli W
    Infect Immun; 1996 May; 64(5):1762-9. PubMed ID: 8613389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
    von Asmuth EJ; Dentener MA; Bazil V; Bouma MG; Leeuwenberg JF; Buurman WA
    Immunology; 1993 Sep; 80(1):78-83. PubMed ID: 7503948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14.
    Schütt C; Schilling T; Grunwald U; Stelter F; Witt S; Krüger C; Jack RS
    Res Immunol; 1995; 146(6):339-50. PubMed ID: 8719658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.
    Hiki N; Berger D; Prigl C; Boelke E; Wiedeck H; Seidelmann M; Staib L; Kaminishi M; Oohara T; Beger HG
    Infect Immun; 1998 Mar; 66(3):1135-41. PubMed ID: 9488406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
    Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
    Corrales I; Weersink AJ; Verhoef J; van Kessel KP
    Immunology; 1993 Sep; 80(1):84-9. PubMed ID: 7503949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
    J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of soluble CD14 in serum from patients with septic shock.
    Landmann R; Reber AM; Sansano S; Zimmerli W
    J Infect Dis; 1996 Mar; 173(3):661-8. PubMed ID: 8627030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
    Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
    Read MA; Cordle SR; Veach RA; Carlisle CD; Hawiger J
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9887-91. PubMed ID: 7694295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation.
    Pugin J; Ulevitch RJ; Tobias PS
    J Exp Med; 1993 Dec; 178(6):2193-200. PubMed ID: 7504060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD14 participates in the response of cells to lipopolysaccharide.
    Frey EA; Miller DS; Jahr TG; Sundan A; Bazil V; Espevik T; Finlay BB; Wright SD
    J Exp Med; 1992 Dec; 176(6):1665-71. PubMed ID: 1281215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of CD14 shedding from human monocytes. Evidence for the competition of soluble CD14 (sCD14) with CD14 receptors for lipopolysaccharide (LPS) binding.
    Rokita E; Menzel EJ
    APMIS; 1997 Jul; 105(7):510-8. PubMed ID: 9269297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.